Delayed-type hypersensitivity to lidocaine

Christine L. Mackley, James Marks, Bryan Anderson

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background: Lidocaine hydrochloride is the preferred anesthetic agent used in outpatient surgical procedures. While type I hypersensitivity reactions to lidocaine are uncommon, type IV hypersensitivity is reported even less frequently. Observations: Between January 1, 2001, and December 31, 2001, 183 patients were patch tested at the Penn State Milton S. Hershey Medical Center (Hershey, Pa) to the North American Contact Dermatitis Group tray. All patients who had a positive patch test reaction to lidocaine were challenged with 0.1 mL of preservative-free 1% lidocaine intradermally. Of the 183 patients patch tested, 4 had positive reactions to lidocaine, 2 of whom had histories of sensitivity to local injections of lidocaine manifested by dermatitis. Conclusions: Delayed-type hypersensitivity to lidocaine may occur more frequently than previously thought. In cases of suspected lidocaine contact type IV sensitivity, patients should be patch tested to lidocaine. Positive patch test reactions should be confirmed by intradermal challenge with lidocaine. To provide the patient with alternative local anesthetics, patch testing should be performed with other injectable anesthetics. If positive patch test results occur, intradermal testing should follow.

Original languageEnglish (US)
Pages (from-to)343-346
Number of pages4
JournalArchives of dermatology
Volume139
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Delayed Hypersensitivity
Lidocaine
Patch Tests
Contact Dermatitis
Anesthetics
Immediate Hypersensitivity
Injections
Dermatitis
Local Anesthetics
Outpatients

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Mackley, Christine L. ; Marks, James ; Anderson, Bryan. / Delayed-type hypersensitivity to lidocaine. In: Archives of dermatology. 2003 ; Vol. 139, No. 3. pp. 343-346.
@article{fc61226c677e48a693e2872d2af81c33,
title = "Delayed-type hypersensitivity to lidocaine",
abstract = "Background: Lidocaine hydrochloride is the preferred anesthetic agent used in outpatient surgical procedures. While type I hypersensitivity reactions to lidocaine are uncommon, type IV hypersensitivity is reported even less frequently. Observations: Between January 1, 2001, and December 31, 2001, 183 patients were patch tested at the Penn State Milton S. Hershey Medical Center (Hershey, Pa) to the North American Contact Dermatitis Group tray. All patients who had a positive patch test reaction to lidocaine were challenged with 0.1 mL of preservative-free 1{\%} lidocaine intradermally. Of the 183 patients patch tested, 4 had positive reactions to lidocaine, 2 of whom had histories of sensitivity to local injections of lidocaine manifested by dermatitis. Conclusions: Delayed-type hypersensitivity to lidocaine may occur more frequently than previously thought. In cases of suspected lidocaine contact type IV sensitivity, patients should be patch tested to lidocaine. Positive patch test reactions should be confirmed by intradermal challenge with lidocaine. To provide the patient with alternative local anesthetics, patch testing should be performed with other injectable anesthetics. If positive patch test results occur, intradermal testing should follow.",
author = "Mackley, {Christine L.} and James Marks and Bryan Anderson",
year = "2003",
month = "3",
day = "1",
doi = "10.1001/archderm.139.3.343",
language = "English (US)",
volume = "139",
pages = "343--346",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "3",

}

Delayed-type hypersensitivity to lidocaine. / Mackley, Christine L.; Marks, James; Anderson, Bryan.

In: Archives of dermatology, Vol. 139, No. 3, 01.03.2003, p. 343-346.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delayed-type hypersensitivity to lidocaine

AU - Mackley, Christine L.

AU - Marks, James

AU - Anderson, Bryan

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background: Lidocaine hydrochloride is the preferred anesthetic agent used in outpatient surgical procedures. While type I hypersensitivity reactions to lidocaine are uncommon, type IV hypersensitivity is reported even less frequently. Observations: Between January 1, 2001, and December 31, 2001, 183 patients were patch tested at the Penn State Milton S. Hershey Medical Center (Hershey, Pa) to the North American Contact Dermatitis Group tray. All patients who had a positive patch test reaction to lidocaine were challenged with 0.1 mL of preservative-free 1% lidocaine intradermally. Of the 183 patients patch tested, 4 had positive reactions to lidocaine, 2 of whom had histories of sensitivity to local injections of lidocaine manifested by dermatitis. Conclusions: Delayed-type hypersensitivity to lidocaine may occur more frequently than previously thought. In cases of suspected lidocaine contact type IV sensitivity, patients should be patch tested to lidocaine. Positive patch test reactions should be confirmed by intradermal challenge with lidocaine. To provide the patient with alternative local anesthetics, patch testing should be performed with other injectable anesthetics. If positive patch test results occur, intradermal testing should follow.

AB - Background: Lidocaine hydrochloride is the preferred anesthetic agent used in outpatient surgical procedures. While type I hypersensitivity reactions to lidocaine are uncommon, type IV hypersensitivity is reported even less frequently. Observations: Between January 1, 2001, and December 31, 2001, 183 patients were patch tested at the Penn State Milton S. Hershey Medical Center (Hershey, Pa) to the North American Contact Dermatitis Group tray. All patients who had a positive patch test reaction to lidocaine were challenged with 0.1 mL of preservative-free 1% lidocaine intradermally. Of the 183 patients patch tested, 4 had positive reactions to lidocaine, 2 of whom had histories of sensitivity to local injections of lidocaine manifested by dermatitis. Conclusions: Delayed-type hypersensitivity to lidocaine may occur more frequently than previously thought. In cases of suspected lidocaine contact type IV sensitivity, patients should be patch tested to lidocaine. Positive patch test reactions should be confirmed by intradermal challenge with lidocaine. To provide the patient with alternative local anesthetics, patch testing should be performed with other injectable anesthetics. If positive patch test results occur, intradermal testing should follow.

UR - http://www.scopus.com/inward/record.url?scp=0037341122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037341122&partnerID=8YFLogxK

U2 - 10.1001/archderm.139.3.343

DO - 10.1001/archderm.139.3.343

M3 - Article

VL - 139

SP - 343

EP - 346

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 3

ER -